Emerging Therapies for Difficult-to-Treat Uterine Cancer: New Options and Hope
About this episode
This episode discusses the latest therapies for difficult-to-treat uterine cancer, focusing on targeted therapy, immune checkpoint inhibitors, hormonal therapy, and radiation therapy.
In this episode, we explore the latest emerging therapies for hard-to-treat uterine cancer and how they help patients with advanced or recurrent endometrial cancer. You’ll learn: How targeted therapy attacks specific tumor cell features while sparing healthy tissue Why do immune checkpoint inhibitors help the immune system recognize and fight cancer cells How hormonal therapy slows growth in hormone-dependent endometrial carcinoma The role of radiation therapy in controlling tu...
More episodes of The Onco Life Podcast
- Long-Term Immunotherapy for ASPS: AACR 2026 Breakthrough in Rare Cancer Treatment
- Why More Young Adults Are Being Diagnosed With Colorectal Cancer
- How Oncologists Create Personalized Treatment Plans for Each Cancer Type
- How Breast Cancer Spreads to Lungs and Bones: Signs, Diagnosis, and Treatment Options
- Can Uterine Cancer Be Treated Without Surgery? Options and Strategies
- Transarterial Chemoembolization (TACE): How It Works for Liver Cancer Treatment
Explore listener stats, chart rankings, contacts and more on the The Onco Life Podcast podcast page.